Table 1.
Baseline Demographics
| Variable | All Patients | Acupressure Group Aα | Acupressure Group Bβ | Acupressure Group A+B | Education | P-value A+B vs C |
|---|---|---|---|---|---|---|
| No of patients | 23 | 8 | 8 | 16 | 7 | |
| Female, N(%) | 18 (78.3%) | 6 (75.0%) | 6 (75.0%) | 12 (75.0%) | 6 (85.7%) | 0.57 |
| Age: mean (SD) | 49.9 (16.0) | 56.3 (20.6) | 48.4 (9.7) | 52.3 (16.1) | 44.3 (15.5) | 0.28 |
| Caucasian, N (%) | 22 (95.7%) | 8 (100%) | 8 (100%) | 15 (93.8%) | 7 (100%) | 0.50 |
| (N)% on vasodilators/warfarin | 7 (30%)/2(8.7%) | 3 (38%)/1(12.5%) | 2(25%)/1(12.5%) | 5 (31%)/2 (12.5%) | 2 (28%), 0 (0%) | |
| Secondary RP, N (%) | 8 (34.8%) | 3 (37.5%) | 3 (37.5%) | 6 (37.5%) | 2 (28.6) | 0.68 |
| No. attacks previous week, mean (SD) | 15.3 (15.0) | 10.4 (5.6) | 16.4 (11.5) | 13.41 (9.3) | 19.6 (24.0) | 0.53 |
| Patient VAS * for RP, mean (SD) | 6.2 (2.6) | 6.8 (2.6) | 6.1 (2.5) | 6.4 (2.5) | 5.8 (3.1) | 0.63 |
| Physician VAS* for RP, mean (SD) | 6.4 (2.3) | 6.7 (2.1) | 6.5 (2.1) | 6.6 (2.0) | 6 (2.9) | 0.66 |
| Pain VAS**, mean (SD) | 30.1 (25.3) | 37.9 (27.7) | 17.9 (16.6) | 30.5 (23.9) | 33.7 (29.4) | 0.69 |
| Tingling VAS **, mean (SD) | 17.0 (19.4) | 14.4 (13.4) | 11.9 (13.5) | 14.5 (12.8) | 23.3 (27.6) | 0.30 |
| Numbness VAS **, mean (SD) | 33.3 (31.7) | 38.7 (40.4) | 14.5 (12.5) | 27.9 (32.5) | 44.4 (32.5) | 0.43 |
| EndoPAT, mean (SD) | 1.6 (0.7) | 1.7 (0.6) | 1.1 (0.2) | 1.5 (0.6) | 1.7 (0.9) | 0.71 |
| EndoPAT for primary RP, mean (SD) | 2.0 (0.8) | 2.3 (0.4) | 1.5 (NA) | 2.0 (0.6) | 2.1 (0.9) | 0.90 |
| EndoPAT for secondary RP, mean (SD) | 1.2 (0.3) | 1.4 (0.5) | 1.0 (NA) | 1.2 (0.4) | 1 (0) | 0.22 |
*
0-10
**
0-100
α
Acupressure Group A= vasodilation
β
Acupressure Group B= relaxation